Syncope and Neuroleptic malignant syndrome - from FDA reports

Summary

Neuroleptic malignant syndrome is reported only by a few people with Syncope. We study 4 people who have Neuroleptic malignant syndrome and Syncope from FDA . Find out below who they are, other conditions they have and drugs they take.

What to expect?

If you have Syncope and Neuroleptic malignant syndrome, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Syncope and Neuroleptic malignant syndrome

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 22, 2017

4 people who have Syncope and Neuroleptic Malignant Syndrome are studied.


Number of reports submitted per year:

Would you have Neuroleptic malignant syndrome when you have Syncope?

Gender of people who have Syncope and experience Neuroleptic Malignant Syndrome *:

  • female: 25 %
  • male: 75 %

Age of people who have Syncope and experience Neuroleptic Malignant Syndrome *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 25 %
  • 60+: 50 %

Top co-existing conditions for these people *:

  • Pneumonia (2 people, 50.00%)
  • Chronic Obstructive Pulmonary Disease (1 person, 25.00%)

Most common drugs for these people *:

  • Ranitidine (2 people, 50.00%)
  • Ondansetron (2 people, 50.00%)
  • Multaq (2 people, 50.00%)
  • Lyrica (2 people, 50.00%)
  • Humalog (2 people, 50.00%)

Top symptoms for these people *:

  • Weight Decreased (2 people, 50.00%)
  • Lung Cancer Metastatic (2 people, 50.00%)
  • Appetite - Decreased (2 people, 50.00%)
  • Pharyngolaryngeal Pain (1 person, 25.00%)
  • Attention Deficit Hyperactivity Disorder (1 person, 25.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Neuroleptic malignant syndrome and Syncope?

Expand the study to include reports from both FDA and eHealthMe

Neuroleptic malignant syndrome and Syncope from FDA and eHealthMe reports

Syncope

Syncope (loss of consciousness with an inability to maintain postural tone) can be treated by Midodrine hydrochloride, Florinef, Metoprolol succinate (latest reports from 74,773 Syncope patients)

Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents) has been reported by people with schizophrenia, depression, bipolar disorder, psychotic disorder, parkinson's disease (latest reports from 9,926 Neuroleptic malignant syndrome patients).

Browse all symptoms of Syncope

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Neuroleptic malignant syndrome

Neuroleptic malignant syndrome

Other conditions that could case Neuroleptic malignant syndrome

Neuroleptic malignant syndrome

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Syncope and Neuroleptic malignant syndrome.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >